Health News Highlights: From Screwworms to Cancer Vaccines

This week's health news covers diverse topics including screwworm detection in Sonora, Mexico, FDA drug approvals for rare disorders, resurgence of Ebola in Congo, dengue outbreaks in Malaysia, and Moderna's breakthrough in cancer vaccines. Other updates include Abbott's legal settlement, malaria outbreaks, and healthcare cost projections.

In Sonora, Mexico, health alerts were triggered upon the first screwworm detection, leading to immediate action plans. This incident underscores the ongoing challenges in controlling zoonotic diseases and ensuring public health safety in the region.

In a significant leap for rare disease treatments, the U.S. FDA approved new drugs by Regeneron and Ultragenyx for unique disorders, highlighting advancements in genetic therapies. Meanwhile, the healthcare sector witnessed legal settlements, like the $670 million that Abbott agreed to pay over formula misuse allegations.

On the vaccine front, Moderna and Merck's personalized mRNA cancer vaccine showed promising results in melanoma management, potentially revolutionizing cancer treatments. In parallel, global health concerns are rising over the spread of diseases such as Ebola in Congo, with WHO's vaccine allocations stepping in to curb the outbreak.